Ohio Behavioral Health and the Role of Drug Testing

The Ohio Department of Mental Health and Addiction Services (OhioMHAS), operating under the Ohio Department of Behavioral Health, is the primary state agency overseeing substance use disorder treatment, recovery housing certification, and behavioral health provider standards. Ohio's behavioral health system serves individuals across the full continuum of care — from early intervention and outpatient counseling through residential rehabilitation, medication-assisted treatment (MAT), and long-term recovery housing. Drug testing is not peripheral to this system — it is a core clinical and compliance tool embedded in every level of care from intake assessment through sustained recovery monitoring.

For Ohio behavioral health providers billing through Medicaid or operating under OhioMHAS certification, point-of-care drug testing must meet specific documentation standards. CLIA-waived urine drug test cups satisfy those requirements for presumptive screening — they can be administered and read by trained non-laboratory staff at the point of care without a CLIA laboratory certificate, generating a documented presumptive result that satisfies Medicaid billing and OhioMHAS audit requirements when confirmed appropriately.

Which Urine Cup Fits Which Ohio Recovery Program?

The chart below maps each of the four cup configurations to the Ohio addiction recovery and behavioral health settings where they are most commonly used — matched by panel breadth, analyte coverage, CLIA status, and program type.

The Four Cups — Brands, Classifications, and Program Fit

DrugScreens.com carries both SAFElife and Healgen urine cups for Ohio behavioral health providers. All four configurations below include a temperature strip and are cleared for point-of-care administration. Three are CLIA waived — one is Forensic Use. Here is the breakdown.

Building an Ohio Recovery Testing Protocol

Ohio recovery programs operating under Ohio behavioral health standards should structure their drug testing protocol around the continuum of care rather than selecting a single cup for all occasions. A well-designed protocol uses different panel configurations at different stages — wider at intake, more targeted for ongoing monitoring, and escalating to comprehensive panels for high-acuity or court-referred populations.

This content is provided for general informational purposes only and does not constitute legal advice. Any employer or organization considering changes to its workplace or in-house drug screening policies should consult with qualified legal counsel and applicable regulatory authorities before implementing, modifying, or discontinuing any testing program or related procedures.